Shopping Cart
Remove All
Your shopping cart is currently empty
Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, with an IC50 of 0.31 nM, targeting SYK, a potential therapeutic target for autoimmunity and hematological cancers[1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $373 | Inquiry | Inquiry | |
| 10 mg | $663 | Inquiry | Inquiry | |
| 25 mg | $1,320 | Inquiry | Inquiry | |
| 50 mg | $2,150 | Inquiry | Inquiry | |
| 100 mg | $3,230 | Inquiry | Inquiry | |
| 1 mL x 10 mM (in DMSO) | $397 | Inquiry | Inquiry |
| Description | Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, with an IC50 of 0.31 nM, targeting SYK, a potential therapeutic target for autoimmunity and hematological cancers[1]. |
| In vitro | Syk-IN-4 is a potent inhibitor of hERG with an IC50 of 3.0 μM[1], and it inhibits SUDHL-4 and T cell proliferation with GI50s of 0.24 μM and 2.6 μM, respectively[1]. |
| In vivo | Syk-IN-4 demonstrates moderate oral bioavailability (60%) when administered orally (1 mg/kg) in male Hans Wistar rats[1], while showing high plasma clearance (151 mL/min/kg) and large volume of distribution (1.0 L/kg respectively) upon intravenous administration (0.5 mg/kg) in the same animal model[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 62.5 mg/mL, Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL, Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.